Convergence Investment Partners, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 140 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Convergence Investment Partners, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2016$529,000
+155.6%
44,905
+181.3%
0.08%
+178.6%
Q2 2016$207,000
-89.2%
15,965
-86.7%
0.03%
-87.8%
Q1 2016$1,923,000
+184.9%
120,251
+589.1%
0.23%
+108.2%
Q4 2013$675,00017,4500.11%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2016
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders